Prevalence of Inflammatory Markers (High-Sensitivity C-Reactive Protein,Nuclear Factor-κB,and Adiponectin) in Indian Patients with Type 2 Diabetes Mellitus with and without Macrovascular Complications

Abstract

Background:

Atherosclerosis is more prevalent in subjects with diabetes mellitus. Recent evidence suggests that diabetic atherosclerosis is not simply a disease of hyperlipidemia, but is also an inflammatory disorder. Our aim was to study the prevalence of inflammatory markers such as high-sensitivity C-reactive protein (hsCRP), adiponectin, and nuclear factor-κB (NF-κB) expression, in peripheral blood mononuclear cells in Indian patients with type 2 diabetes mellitus (T2DM) with and without macrovascular disease (MVD).

Methods:

A total of 29 consecutive cases of T2DM with proven MVD (group A), 28 matched cases without MVD (group B), and 14 healthy controls (group C) were evaluated for the clinical parameters fasting blood glucose (FBG), 2-h postprandial blood glucose (PPBG), glycosylated hemoglobin (HbA1c), lipid profile, and the above-mentioned inflammatory markers.

Results:

Diabetic subjects with T2DM had higher hsCRP and NF-κB expression and lower values of adiponectin compared to healthy controls. Group A had significantly higher serum hsCRP than group B (P=0.0001) despite comparable values of BMI, FBG, 2-h PPBG, HbA1c, and lipid parameters. Group A had significantly higher serum hsCRP and NF-κB expression and significantly lower levels of adiponectin than group C (P=0.0001, 0.007, and 0.02, respectively). In Group A, serum adiponectin negatively correlated with NF-κB expression. In Group B, adiponectin values correlated negatively with both FBG and 2-h PPBG.

Conclusions:

Indian subjects with T2DM with or without MVD had higher hsCRP and lower adiponectin values as compared to healthy controls, whereas hsCRP was significantly higher in those with MVD, suggesting that our patients with T2DM were in a proinflammatory state.

Get full access to this article

View all access options for this article.

References

Das

. Macrovascular disorders in diabetes: Determinants and risk factors. Tripathy

. RSSDI Textbook of Diabetes Mellitus, 2nd 2. The National Book Depot, 2008; 863–870.

Pickup

. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 2004; 27:813–823.

Devaraj

, Dasu

, Jialal

. Diabetes is a pro-inflammatory state: A translational perspective. Expert Rev Endocrinol Metab, 2010; 5:19–28.

Shanmugam

, Reddy

, Guha

et al. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes, 2003; 52:1256–1264.

Dandona

, Aljada

, Chaudhuri

et al. Metabolic syndrome. A comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation, 2005; 111:1448–1454.

Kawano

, Arora

. The role of adiponectin in obesity, diabetes and cardiovascular disease. J Cardiometab Syndr, 2009; 4:44–49.

Schiekofer

, Andrassy

, Chen

et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK and nuclear Factor κB in PBMCs. Diabetes, 2003; 52:621–633.

Dr Thomas Gilmore. NF-κB transcription factors. www.bu.edu/nf-kb/. 2012 January 15.

Sen

, Baltimore

. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 1986; 46:705–716.

10.

Snehalata

, Viswanathan

, Ramachandran

. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care, 2003; 26:1380–1384.

11.

Barba

, Cavalli-Sforza

, Cutter

et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 2004; 363:157–163.

12.

Devaraj

, Valleggi

, Siegel

et al. Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep, 2010; 12:110–118.

13.

Pfutzner

, Forst

. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther, 2006; 8:28–36.

14.

Kimberly

, Cooper

, Myers

. An overview of inflammatory markers in type 2 diabetes from the perspective of the clinical chemist. Diabetes Technol Ther, 2006; 8:37–44.

15.

Mohan

, Deepa

. Adipocytokines and the expanding ‘Asian Indian phenotype’ J Assoc Physicians India, 2006; 54:685–686.

16.

Sadikot

, Nigam

, Das

et al.

Diabetes India. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: Prevalence of diabetes in India study (PODIS)

Diabetes Res Clin Pract, 2004; 66:301–307.

17.

, Zhang

, Wang

et al. Adiponectin inhibits lymphotoxin-β receptor-mediated NF-κB signaling in human umbilical vein endothelial cells. Biochem Biophys Res Commun, 2011; 404:1060–1064.

18.

Kazumi

, Kawaguchi

, Sakai

et al. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care, 2002; 5:971–976.